Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIL0A.L Regulatory News (IL0A)

  • There is currently no data for IL0A

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

23 Jun 2022 10:03

RNS Number : 9529P
Morgan Stanley & Co. Int'l plc
23 June 2022
 

23 June 2022

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

PERMANENT TSB GROUP HOLDINGS P.L.C.

Pre-stabilisation Period Announcement

Morgan Stanley & Co. International plc (contact: Morgan Stanley Debt Syndicate - Matteo Benedetto - +44 20 7677-3409) hereby gives notice, as Coordinating Stabilisation Manager, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014 and/or the UK FCA Stabilisation Binding Technical Standards.

Securities

Issuer:

PERMANENT TSB GROUP HOLDINGS P.L.C.

Guarantor(s) (if any):

N/A

Aggregate nominal amount:

To be confirmed

Description:

EUR Fixed Rate Senior Notes due 2025

Offer price:

To be confirmed

 

Stabilisation

Stabilisation Manager(s):

BofA Securities Europe SA

Citigroup Global Markets Limited

Goldman Sachs International

Morgan Stanley & Co. International plc

Stabilisation period expected to start on:

The date of this announcement

Stabilisation period expected to end no later than:

29 July 2022

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilisation Manager(s) may over-allot the securities to the extent permitted in accordance with applicable law

Stabilisation trading venue(s):

Irish Stock Exchange Regulated Market (Euronext Dublin)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

If and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with Regulation (EU) 2017/1129 (the "EEA Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the EEA Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the EEA Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

If and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, the UK before the publication of a prospectus in relation to the securities which has been approved by the competent authority in the UK in accordance with Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the "UK Prospectus Regulation"), this announcement and the offer are only addressed to and directed at persons in the UK who are qualified investors within the meaning of the UK Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in the UK.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAFJMLTMTMTMBT
Date   Source Headline
26th Nov 20203:30 pmRNSDirector Declaration
25th Nov 20202:22 pmRNSStabilisation Notice
18th Nov 20209:10 amRNSStabilisation Notice
3rd Nov 20207:00 amRNSTrading Statement
27th Oct 20207:00 amRNSSale of Buy To Let Loan Portfolio
12th Oct 20202:00 pmRNSDirector Declaration
29th Sep 20204:30 pmRNSAppointment of Senior Independent Director
25th Sep 202010:00 amRNSAppointment of Interim CFO
12th Aug 20204:00 pmRNSDirector/PDMR Shareholding
5th Aug 20203:00 pmRNSDirectorate Change
5th Aug 20203:00 pmRNSResult of AGM
4th Aug 20207:00 amRNSCommentary on Half-Year Report
4th Aug 20207:00 amRNSHalf-year Report
6th Jul 202012:00 pmRNSNotice of AGM
6th Jul 202012:00 pmRNSEuronext Listing Rules 6.1.82(1) & (2) Disclosure
22nd Jun 202010:00 amRNSAppointment of Chief Executive Officer
14th May 20207:00 amRNSTrading Statement
20th Mar 202012:00 pmRNSConvening of Annual General Meeting Deferred
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
26th Feb 20207:00 amRNSCommentary on Annual Financial Report
26th Feb 20207:00 amRNSAnnual Financial Report
24th Feb 20204:41 pmRNSSecond Price Monitoring Extn
24th Feb 20204:37 pmRNSPrice Monitoring Extension
28th Jan 20204:00 pmRNSDirectorate Change
6th Nov 20197:00 amRNSTrading Statement
29th Oct 20194:00 pmRNSDirector Declaration
29th Oct 20193:00 pmRNSDirectorate Change
24th Oct 20192:00 pmRNSChief Executive To Step Down During 2020
2nd Oct 201910:00 amRNSDirector Declaration
26th Sep 201912:27 pmRNSStabilisation Notice
24th Sep 20193:30 pmRNSDirectorate Changes
19th Sep 20195:00 pmRNSDirector Declaration
19th Sep 201911:17 amRNSStabilisation Notice
12th Sep 20192:00 pmRNSSale of Non-Performing Loan Portfolio
3rd Sep 201911:00 amRNSDirector/PDMR Shareholding
3rd Sep 201911:00 amRNSDirector/PDMR Shareholding
6th Aug 20194:00 pmRNSDirector/PDMR Shareholding
29th Jul 201910:00 amRNSDirector/PDMR Shareholding
29th Jul 201910:00 amRNSDirector/PDMR Shareholding
26th Jul 20195:00 pmRNSHalf-year Report
25th Jul 20197:00 amRNSHalf-year Report
25th Jul 20197:00 amRNS2019 Half Year Report Commentary
30th May 20192:00 pmRNSConclusion of Tracker Enforcement Investigation
14th May 20194:30 pmRNSResult of AGM
9th May 20197:00 amRNSTrading Update
29th Mar 20193:30 pmRNSNotice of AGM
27th Feb 20197:00 amRNSAnnual Financial Report
27th Feb 20197:00 amRNS2018 Full Year Report Commentary
29th Nov 20184:00 pmRNSSecuritisation of a Non-Performing Loan Portfolio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.